Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

377
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
377
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

1.6K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.6K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

703
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
703

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Observations on an Open-Label Phase 1/2 Dopamine Gene Therapy Trial (OXB-102/Axo-Lenti-PD) in People with Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Multi-locus genetic dosage shapes cognitive disease progression in Parkinson's patients: 15-year meta-analysis of 24 cohorts.

NPJ Parkinson's disease·2026
Same author

Early α-synuclein-mediated mitochondrial dysfunction in a human cell model of Parkinson's disease dementia.

Communications biology·2026
Same author

rAAV Fbxo7 gene therapy rescues the progressive nigrostriatal pathology in a mouse model of juvenile parkinsonism.

Acta neuropathologica communications·2026
Same author

Stem cell treatments and Parkinson's disease: Science and misconceptions.

Journal of Parkinson's disease·2026
Same author

The challenges of choosing your pluripotent stem cell line.

Stem cell reports·2026

Video Experimental Relacionado

Updated: Sep 10, 2025

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies
12:13

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

7.3K

Adición a las terapias de reemplazo basadas en células de dopamina

Saeed Kayhanian1,2, Roger A Barker1,3

  • 1Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 2PY, United Kingdom sk776@cam.ac.uk rab46@cam.ac.uk.

Cold Spring Harbor perspectives in medicine
|August 26, 2025
PubMed
Resumen

Este apéndice actualiza las terapias de reemplazo basadas en células dopaminérgicas al analizar tres nuevos estudios. Estos hallazgos son cruciales para avanzar en las terapias de células dopaminérgicas y los tratamientos de la enfermedad de Parkinson.

Más Videos Relacionados

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

309
Directed Dopaminergic Neuron Differentiation from Human Pluripotent Stem Cells
06:40

Directed Dopaminergic Neuron Differentiation from Human Pluripotent Stem Cells

Published on: September 15, 2014

16.7K

Videos de Experimentos Relacionados

Last Updated: Sep 10, 2025

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies
12:13

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

7.3K
Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

309
Directed Dopaminergic Neuron Differentiation from Human Pluripotent Stem Cells
06:40

Directed Dopaminergic Neuron Differentiation from Human Pluripotent Stem Cells

Published on: September 15, 2014

16.7K

Área de la Ciencia:

  • La neurociencia
  • La Medicina Regenerativa
  • Terapia con células

Sus antecedentes:

  • Las terapias de reemplazo basadas en células de dopamina ofrecen tratamientos potenciales para enfermedades neurodegenerativas.
  • Los avances recientes son críticos para el progreso de este campo terapéutico.

Objetivo del estudio:

  • Proporcionar una actualización sobre estudios recientes significativos en la terapia de reemplazo basada en células de dopamina.
  • Para ofrecer un breve comentario sobre las implicaciones de estos nuevos hallazgos.

Principales métodos:

  • Revisión de tres estudios recientemente publicados relacionados con las terapias de reemplazo basadas en células dopaminérgicas.
  • Análisis y síntesis de los principales resultados de los estudios seleccionados.

Principales resultados:

  • Las nuevas investigaciones proporcionan datos significativos que impactan en el campo de las terapias celulares de dopamina.
  • Estos estudios ofrecen información sobre la eficacia y los desafíos de los tratamientos basados en células.

Conclusiones:

  • Los estudios analizados representan un avance importante en las terapias de reemplazo basadas en células dopaminérgicas.
  • La investigación continua y los comentarios son vitales para avanzar en las estrategias terapéuticas para afecciones como la enfermedad de Parkinson.